4//SEC Filing
Stergiou Angelos M. 4
Accession 0001209191-19-001612
CIK 0001390478other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:03 PM ET
Size
5.6 KB
Accession
0001209191-19-001612
Insider Transaction Report
Form 4
Stergiou Angelos M.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2018-12-31$1.25/sh−23,277$29,189→ 426,858 total
Footnotes (2)
- [F1]The Reporting Person sold such shares to cover personal income tax liability.
- [F2]The price reported is a weighted average price. The shares were sold at prices ranging from $1.23 to $1.31 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001724253
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 9:03 PM ET
- Size
- 5.6 KB